Stemimage Technologies

stemimage technologies is revolutionizing the way we classify and generate unique cell types differentiated from human pluripotent stem cells. with stemimage technology, researchers can generate an unlimited number of cell types on demand for drug discovery and regenerative medicine purposes. they have created the world’s first neural network model that makes it robust, unbiased, and scalable for cell classification because of a novel idea for their pipeline technology using convolutional neural network architecture. they are planning to apply for a patent associated with their pipeline technology for cell classification and generation from human pluripotent stem cells by 2023. at present, the company is running by founder (ceo) zhuohang (alice) feng who has experience in stem cell, and cancer research and co-founder changda li with experience in machine learning and mechatronics engineering. stemimage technologies is looking for help finding a series a investment and are looking for m